Innovation, collaboration, increased capital, and competition from new market entrants are disrupting the health care and life sciences industry and enabling game-changing transactions.
During the 2019 J.P. Morgan Healthcare Conference, McDermott and EY have teamed up to help you embrace these opportunities and meet the challenges head on. We’ll be joined by leading professionals from across the industry to discuss how to position your organization to innovate, collaborate and grow in this dynamic environment.
Our proven team of health, life sciences, regulatory, and transactions partners will be onsite at JPM. We look forward to discussing how McDermott can help you go further.
The Ritz-Carlton San Francisco | January 7, 2019
9:30 am – 10:30 am PST – Registration
10:30 am – 1:50 pm PST – Program
12:05 pm – 1:05 pm PST – Keynote Luncheon
As today’s hospital and health system market faces new levels of disruption, experts are teaming up to embrace the opportunities and meet the challenges head-on. The transformation from fee-for-service to value-based purchasing is driving new and creative care delivery models, which demand flexibility and a tolerance for risk. Innovation brings new solutions and technologies to the table—along with increased competition from entities outside the health ecosystem. And capital-rich markets enable game-changing transactions, impactful to a system’s long-term financial strategies.
Leading professionals from across the industry will discuss how to position your organization to innovate, collaborate and grow in this dynamic environment.
The Ritz-Carlton San Francisco | January 8, 2019
8:00 am – 8:30 am PST – Registration
8:30 am – 1:30 pm PST – Program
1:30 pm – 2:30 pm PST – Networking Luncheon
Hear directly from senior management at health care and life sciences companies, private equity investment professionals and industry specialists about today’s biggest trends and dealmaking opportunities. More than 150 private equity firms and 100 health care services companies expected to attend this fast-paced, half-day program, You won’t want to miss out on these needle-moving connections.
The Ritz-Carlton San Francisco | January 7, 2019
4:00 pm – 4:30 pm PST – Registration and Networking
4:30 pm – 6:00 pm PST – Program
6:00 pm – 7:00 pm PST – Networking Reception
An experienced panel of industry leaders will discuss the dynamics and recent policy changes impacting cross-border investment and partnership between life sciences companies and investors in China, Europe and the US. The panel is hosted by McDermott Will & Emery, Healthcare Drinks and the Sino-American Pharmaceutical Association (SAPA). A networking cocktail reception will immediately follow the panel.
The Ritz-Carlton San Francisco | January 9, 2019
11:00 am – 11:30 am PST – Registration and Networking
11:30 am – 1:00 pm PST – Program and Lunch
1:00 pm – 1:30 pm PST – Networking
Digital health pioneers Peggy Baxter, Chief of Staff and Vice President of Network Engagement, AVIA Health Innovation, Selin Kurnaz, PhD, Co-founder and CEO, Massive Bio, Inc., Pierre Leurent, founder and CEO, Voluntis and Elia Stupka, Chief Analytics Officer and SVP - Life Sciences Business, Health Catalyst will share their journeys and the opportunities and obstacles they have faced in their quests to re-shape health care services, quality and access with new and innovative products.
Legal Notices | Privacy Policy
Attorney Advertising
10:30 – 10:35 AM
Welcome & Opening Remarks
10:35 – 11:20 AM
Health Care Technology Mini-Boom:
Maximizing the Benefits through Collaborative Arrangements
The health care technology mini-boom is well under way and hospitals and health systems are exploring ways to maximize the benefits. They are capitalizing on opportunities through collaborative arrangements with tech companies, developing and commercializing new technologies expanding their reach through virtual care and providing platforms for the development of technology designed to improve operations. This panel will discuss the benefits, challenges, goals and outcomes of these arrangements and how they vary, including:
- Creation of efficiencies in operations
- Developing innovation centers and providing access to technology for health care operations
- Using data/experience for development of new medical technologies
- Increasing revenue and/or equity opportunities
- Redesigning patient engagement strategies
Mudit Garg, Chief Executive Officer & Founder, Qventus
David Dai, Partner, MWE China Law Offices
Carla Small, Senior Director of the Innovation and Digital Health Accelerator, Boston Children’s Hospital
Moderator: Dale Van Demark, Partner & Program Co-Chair
11:20 AM – 12:05 PM
Access to Capital and Other Keys to Successful Transformative Transactions
Transactions, many driven by access to capital, are reshaping what hospital systems of the future looks like. In this session, a panel of top senior health care executives and advisors will analyze transformative transactions including REIT transactions and non-profit to for-profit conversion transactions. In addition, the panelists will discuss and analyze the trends that are disrupting the traditional hospital business. We will explore access to capital strategies and other key strategic questions:
- How much of today’s transactional activity is driven by access to capital? What other strategic imperatives and value propositions are driving transactions activity?
- REIT financings are common in the post-acute space—why are they rare for acute care hospitals?
- What should hospitals and health systems expect in the future, especially with respect to the many players in the market focused on limiting acute inpatient hospital utilization and spending?
- As the lines being traditional market segments blur (e.g., the line between hospital and non-hospital care, the line between provider and payor) what should hospital systems do to thrive?
Brett Hickman, Executive Vice President, Optum
Sara Rau, Deputy General Counsel, Steward Health Care System LLC
Mark Rich, Healthcare Executive: Finance, Strategy & Business Development Expertise, Steward Health Care System LLC
Co-Moderators
Charles Buck, Partner & Program Co-Chair, McDermott Will & Emery
Ross Nelson, Managing Director, Healthcare Provider Leader, EY-Parthenon
12:05 – 1:05 PM
Networking Luncheon & Keynote
Delos Cosgrove, MD, Former Chief Executive Officer & President, Cleveland Clinic
Moderator: Stephen Bernstein, Partner, McDermott Will & Emery
1:05 – 1:50 PM
Collaborative Transformation: The Impact of Market Innovators
Health systems are considering alternative strategies as they are faced with increasing competition from traditional and non-traditional health industry participants. In an effort to profoundly change the way patients obtain care, health systems have looked to collaborate with others in an effort to make health care more affordable and equitable while improving the consumer experience. Learn from a panel of top market players who are working to drive and deliver game-changing innovations and shape the future of health care.
Nicholas Archer, Chief Executive Officer, Project Fulcrum, Florida Hospital
Richard Mulry, Chief Operating Officer, True North
Patrick Pilch, CPA, MBA, Managing Director and National Leader, BDO
Scott Powder, Chief Strategy Officer, Advocate Aurora Health
Moderator: Kerrin Slattery, Partner & Program Co-Chair, McDermott Will & Emery
8:00 – 8:30 AM
Networking Breakfast
8:30 – 8:45 AM
Welcome and Opening Remarks - 2018 in Review and 2019 Outlook
Ira Coleman, Chairman & Program Co-Chair, McDermott Will & Emery
Gregg Slager, EY Global Health TAS Leader, Program Co-Chair, EY
Kristian Werling, Partner & Program Chair, McDermott Will & Emery
8:45 – 9:30 AM
Smart Health Care Investing in 2019: Understanding New Sectors and What’s Driving Valuations
An interactive panel of senior private equity professionals who are active investors and bankers in the health care services industry providing their perspective on hot sectors, growth strategies for portfolio companies and the outlook for dealmaking in 2019.
Russell Herakovich, Managing Director, Brightwood Capital Advisors
Geoffrey Lieberthal, Partner, Lee Equity
Thomas Scully, General Partner, Welsh, Carson, Anderson & Stowe
Dan Shoenholz, Managing Director, Co-Head of Health Care, EY-Parthenon
Moderator: Kristian Werling, Partner & Program Co-Chair, McDermott Will & Emery
9:30 –10:15 AM
Health Care Regulatory and Policy Outlook Post-Mid Term Elections
With record voter turnout, the midterm elections brought Democratic control of the House, along with several high-profile Senate and gubernatorial races. After the election dust has settled, what are the implications for the US health care system? Our Washington insiders analyze the policy implications and potential impacts for health care services investing.
Jon Blum, Managing Principal, Health Management Associates
Kim Monk, Managing Director, Capital Alpha Partners
Erica Pham, Deputy General Counsel, Head of Government Affairs, Clover Health
Piper Su, Division Chair, Community and Government Engagement, Mayo Clinic
Moderator: Eric Zimmerman, Partner, McDermott Will & Emery
10:15 – 11:00 AM
Collaborative Transformation: Doing Deals Across Divides
Unique partners are joining forces to innovate in bold and unexpected ways. New players are disrupting health care services, life sciences and payors and capital-rich markets enable game-changing transactions. These deals include payors buying providers, biotechs acquiring data mining solutions, providers and employers contracting with Amazon, among others. This panel will discuss key considerations for dealmakers leading transactions that collaborate across traditional divides.
John Callahan, Partner, McDermott Will & Emery
Sarah Hogan, Partner, McDermott Will & Emery
Tom Moriarty, Executive Vice President, Chief Policy & External Affairs Officer & General Counsel, CVS Health
Peter Orszag, Head of North American M&A & Vice Chairman of Investment Banking, Lazard Freres & Co LLC
Moderator: Stephen Bernstein, Partner, McDermott Will & Emery
11:00 – 11:45 AM
“JPM Talks” - Key Insights from Health Care Leaders
New series of “TED Talk” style presentations addressing a brief but in-depth guide into issues impacting health care investors in 2019. Each discussion will be followed by a brief Q&A and opportunity for questions from the audience.
Peter Gates, Executive Advisor, EY-Parthenon
Update: The Impact of Private Equity Investing in Healthcare Service
Robert Galvin, Chief Executive Officer, The Blackstone Group
Consumer Driven Health Care
Jeff Woods, Managing Director, Co-Head of Health Care, EY-Parthenon
Macroforces Impacts the U.S. Healthcare System
Moderator: Kristian Werling, Partner & Program Co-Chair McDermott Will & Emery
11:45 AM – 12:15 PM
Networking Break
12:15 – 1:00 PM
Behavioral Health: Opportunities and Landmines
A variety of behavioral health subsectors continue to be attractive investment opportunities, including eating disorder, developmental disabilities, addiction treatment, inpatient, outpatient and home care. This panel will feature an in-depth analysis to what is driving behavioral health investments and the supply/demand imbalance of the behavioral health markets. Specifically, the panel will discuss what investors need to know about the opioid addiction crises, plus risks and opportunities related to this national epidemic.
Mehran Ahmed, Principal, Webster Capital
Rajat Duggal, Partner, FFL Partners
Fred Levenson, Partner, McDermott Will & Emery
Dominic Sirianni, Chief Executive Officer, Delphi Behavioral Health
Moderator: Dave Nierenberg, Managing Director, EY-Parthenon
1:00 – 1:45 PM
Next Generation of Physician Practice Management & DPM
Physician practice management deal volumes and transaction values continue to charge ahead. However, reimbursement changes are top-of-mind and strategies for aligning incentives with physician’s present challenges to dealmakers and physician leaders. Senior executives of growing PPMs and investment bankers discuss market trends and acquisition strategies in this highly competitive marketplace.
Dr. Stuart Bernsen, DC, Chief Executive Officer, Medulla LLC
Aaron Feinberg, Vice President, Healthcare and Private Equity, EY-Parthenon
David Pegg, Chief Development Officer, Dental Care Alliance
Frank Winslow, Partner, Quad-C Management
Moderator: Joel Rush, Partner, McDermott Will & Emery
1:45 – 2:45 PM
Networking Luncheon
4:00 – 4:30 PM
Registration and Networking
4:30 – 4:45 PM
Welcome and Introduction
Emmanuelle Trombe, Partner, McDermott Will & Emery
Brian Hakim, Founder, Healthcare Drinks
Jerry (Wansheng) Liu, President Elect, Sino-American Pharmaceutical Professionals Association
4:45 – 5:45 PM
Panel Discussion
Rüdiger Herrmann, Partner, McDermott Will Emery
Antoine Papiernik, Chairman, Sofinnova Partners
Steven Shill, Partner & National Leader of Healthcare Industry Group, BDO
Jonathan Wang, Co-Founder & Partner, OrbiMed Asia
Lianshan Zhang, President of Global R&D, Jiangsu Hengrui Medicine
Co-Moderators
Michelle Gon, Partner, McDermott Will & Emery
Evelyne Nguyen, Founder & Chief Executive Officer, ANMPartners
5:45 – 6:00 PM
Q&A from the Audience
6:00 – 7:00 PM
Networking Reception
11:00 – 11:30 AM
Registration and Networking
11:30 AM – 1:00 PM
Interview with Digital Health Pioneers
Peggy Baxter, Chief of Staff & Vice President of Network Engagement, AVIA
Selin Kurnaz, PhD, Co-founder & Chief Executive Officer, Massive Bio, Inc.
Pierre Leurent, Chief Executive Officer, Voluntis
Elia Stupka, Chief Analytics Officer & Senior Vice President, Life Sciences Business, Health Catalyst Inc.
Co-Moderators
Sarah Hogan, Partner, McDermott Will & Emery
Lisa Schmitz Mazur, Partner, McDermott Will & Emery
Dale Van Demark, Partner, McDermott Will & Emery
1:00 – 1:30 PM
Networking